Clinical Heart and Vascular Center
The end of the year is always an exciting time at UT Southwestern. That’s because the findings we spotlight at the annual American Heart Association (AHA) Scientific Sessions – whether moderating, presenting new discoveries, or sharing clinical advances – fuels discussion beyond this remarkable conference well into the following year.
We hope to continue these conversations with you throughout 2022 and beyond. Be on the lookout for the printed version of this special issue of Physician Update, which will arrive in your mailboxes early in the year.
In the meantime, please enjoy the information contained in the reports linked below. It is our pleasure and privilege to make them available to you.
Drazner shares goals as incoming President of HFSA
UT Southwestern’s Mark Drazner, M.D., M.Sc., has begun his term as President of the Heart Failure Society of America and predicts a key role for HFSA in forthcoming medical advances aimed at reducing the impact of heart disease.
Farr joins UTSW as Section Chief of Heart Failure
Nationally recognized cardiologist Maryjane Farr, M.D., has joined UT Southwestern as Section Chief of Heart Failure, VAD, and Transplant. Previously, she directed the Adult Heart Transplant Program at the Columbia University Irving Medical Center.
Cardiology at UT Southwestern: A Year of Achievement
We are enormously proud of the many accomplishments of our Cardiology team at UT Southwestern. Now ranked first in Texas and #11 in the nation, our various endeavors continue to have a robust impact on cardiovascular science and medicine.
Cardiovascular Health in Women
by Ann Marie Navar, M.D., Ph.D.
SGLT2 Inhibition in Acute Decompensated Heart Failure: Another Win for this Remarkable Class of Medications
by Mark H. Drazner, M.D., M.Sc.
Polypill Therapy and Risk of Adverse Cardiovascular Events and Mortality
by Ambarish Pandey, M.D., and Shreya Rao, M.D.
A Blurred Line: What’s the Distinction Between Primary and Secondary Prevention Today?
by Amit Khera, M.D., M.Sc.
High-Sensitivity Troponin and Type 2 MI: Patient Characteristics and Impact on the Health System
by Rebecca Vigen, M.D.
Rapid-Fire Results from AHA Research on COVID-19
by James de Lemos, M.D.
Circulation Symposium at #AHA21
by Joseph A. Hill, M.D., Ph.D.
LV Structure and Function in Duchenne Muscular Dystrophy Female Carriers
by Hannah Lehrenbaum, M.D., and Rahul Sheth, M.D., and Pradeep P.A. Mammen, M.D.
Supranormal LVEF
by Sonia Shah, M.D. and Ambarish Pandey, M.D.
Hemodynamic Support in Management of Cardiogenic Shock
by Dharam Kumbhani, M.D., S.M.
South Asian Ethnicity as a Risk Enhancer for Heart Disease
by Parag Joshi, M.D.
Highlighting Advances in Electrophysiology
by Jose Joglar, M.D.
At the Nexus of Cardiology and Oncology
by Vlad G. Zaha, M.D., Ph.D. and Anjali Rao, M.D.
Cardiometabolic Risk in South Asians
by Anand Rohatgi, M.D.
Do Coronary Artery Calcium Scores Improve Risk Assessment for Individuals with Low Socioeconomic Status?
by Taylor Triana, M.D., M.B.A. and Amit Khera, M.D., M.Sc.
Coronary Angiography and Out-of-Hospital Cardiac Arrest
by Patrick Dale, M.D. and Purav Mody, M.D.
Challenging the Hemodynamic Hypothesis in HFpEF: Is Exercise Capacity Limited by Elevated Pulmonary Capillary Wedge Pressure?
by James P. MacNamara, M.D., M.S.C.S., Satyam Sarma, M.D., and Benjamin D. Levine, M.D.
DOACs for LV Thrombus: The Experience from a Safety Net Hospital
by Anne Marie Kerchberger, M.D., M.Eng., Sandeep Das, M.D., M.P.H., and Rina Mauricio, M.D.
